Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Clinical Oncology

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10147-015-0906-4PMID 26411315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

  2016cited by this paper
• Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer

  2015influential reference
• Prevalence and differentiation of hereditary breast and ovarian cancers in Japan

  2015cited by this paper
• PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo

  2014cited by this paper
• Breast-cancer risk in families with mutations in PALB2.

  2014cited by this paper
• Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing

  2014cited by this paper
• Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada

  2014cited by this paper
• Prevalence of PALB2 Mutations in Breast Cancer Patients in Multi-Ethnic Asian Population in Malaysia and Singapore

  2013cited by this paper
• The complex genetic landscape of familial breast cancer

  2013cited by this paper
• Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

  2013cited by this paper
• Hereditary Breast Cancer in the Han Chinese Population

  2013cited by this paper
• Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer

  2013cited by this paper
• An integrated map of genetic variation from 1,092 human genomes

  2012cited by this paper
• Novel germline PALB2 truncating mutations in African American breast cancer patients

  2012cited by this paper
• Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.

  2011cited by this paper
• PALB2 mutations in German and Russian patients with bilateral breast cancer

  2010cited by this paper
• PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations

  2010cited by this paper
• PALB2/FANCN: recombining cancer and Fanconi anemia.

  2010cited by this paper
• Cross‐sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

  2008cited by this paper
• PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

  2007cited by this paper
• A recurrent mutation in PALB2 in Finnish cancer families

  2007cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

  2002cited by this paper
• Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.

  2001cited by this paper

• Low prevalence of germline TP53 and PALB2 mutations in unselected cohort of breast cancer patients from Brunei Darussalam

  2023cites this paper
• PALB2 Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer

  2023cites this paper
• Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.

  2023cites this paper
• Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors

  2022cites this paper
• PALB2 upregulation is associated with a poor prognosis in pancreatic ductal adenocarcinoma

  2021cites this paper
• The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data.

  2021cites this paper
• Fanconi Anemia Pathway: Mechanisms of Breast Cancer Predisposition Development and Potential Therapeutic Targets

  2020cites this paper
• Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan

  2018influential citation
• The Role of PALB2 in the DNA Damage Response and Cancer Predisposition

  2017cites this paper
• Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer

  2017cites this paper
• PALB2 mutation in a woman with bilateral breast cancer: A case report.

  2017cites this paper
• Mutation status of RAD51C,PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations

  2017cites this paper
• Frequency of germline PALB2 mutations among women with epithelial ovarian cancer

  2016cites this paper
• miR-146 a and miR-196 a 2 polymorphisms in ovarian cancer risk

  2016cites this paper